By Taylor Arluck ( April 13, 2018, 7:39 PM EDT) -- An Illinois federal judge Friday refused to toss nationwide class claims from a suit alleging Pfizer Inc. overcharged consumers for its "Maximum Strength" Robitussin compared to its regular version, finding that the label could be plausibly considered deceptive based on the drugs' relative ingredient mixes....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.